Correlation between fertility drugs use and malignant melanoma incidence: the state of the art

Federica Tomao, Anselmo Papa, Giuseppe Lo Russo, Sara Zuber, Gian Paolo Spinelli, Luigi Rossi, Davide Caruso, Natalie Prinzi, Valeria Stati, Pierluigi Benedetti Panici, Silverio Tomao

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma.

Original languageEnglish
Pages (from-to)8415-8424
Number of pages10
JournalTumor Biology
Volume35
Issue number9
DOIs
Publication statusPublished - Oct 9 2014

Fingerprint

Fertility Agents
Melanoma
Incidence
Fertility
Melanocytes
Pigmented Nevus
Estrogen Receptors
Growth Hormone
Appointments and Schedules
Estrogens
Therapeutics
Hormones
Skin
Pharmaceutical Preparations

Keywords

  • Fertility drugs
  • In vitro fertilization
  • Infertility
  • Invasive melanoma
  • Ovarian stimulation

ASJC Scopus subject areas

  • Cancer Research
  • Medicine(all)

Cite this

Tomao, F., Papa, A., Lo Russo, G., Zuber, S., Spinelli, G. P., Rossi, L., ... Tomao, S. (2014). Correlation between fertility drugs use and malignant melanoma incidence: the state of the art. Tumor Biology, 35(9), 8415-8424. https://doi.org/10.1007/s13277-014-2230-4

Correlation between fertility drugs use and malignant melanoma incidence : the state of the art. / Tomao, Federica; Papa, Anselmo; Lo Russo, Giuseppe; Zuber, Sara; Spinelli, Gian Paolo; Rossi, Luigi; Caruso, Davide; Prinzi, Natalie; Stati, Valeria; Benedetti Panici, Pierluigi; Tomao, Silverio.

In: Tumor Biology, Vol. 35, No. 9, 09.10.2014, p. 8415-8424.

Research output: Contribution to journalArticle

Tomao, F, Papa, A, Lo Russo, G, Zuber, S, Spinelli, GP, Rossi, L, Caruso, D, Prinzi, N, Stati, V, Benedetti Panici, P & Tomao, S 2014, 'Correlation between fertility drugs use and malignant melanoma incidence: the state of the art', Tumor Biology, vol. 35, no. 9, pp. 8415-8424. https://doi.org/10.1007/s13277-014-2230-4
Tomao, Federica ; Papa, Anselmo ; Lo Russo, Giuseppe ; Zuber, Sara ; Spinelli, Gian Paolo ; Rossi, Luigi ; Caruso, Davide ; Prinzi, Natalie ; Stati, Valeria ; Benedetti Panici, Pierluigi ; Tomao, Silverio. / Correlation between fertility drugs use and malignant melanoma incidence : the state of the art. In: Tumor Biology. 2014 ; Vol. 35, No. 9. pp. 8415-8424.
@article{064547daea324f47a361260a4de25683,
title = "Correlation between fertility drugs use and malignant melanoma incidence: the state of the art",
abstract = "The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma.",
keywords = "Fertility drugs, In vitro fertilization, Infertility, Invasive melanoma, Ovarian stimulation",
author = "Federica Tomao and Anselmo Papa and {Lo Russo}, Giuseppe and Sara Zuber and Spinelli, {Gian Paolo} and Luigi Rossi and Davide Caruso and Natalie Prinzi and Valeria Stati and {Benedetti Panici}, Pierluigi and Silverio Tomao",
year = "2014",
month = "10",
day = "9",
doi = "10.1007/s13277-014-2230-4",
language = "English",
volume = "35",
pages = "8415--8424",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "9",

}

TY - JOUR

T1 - Correlation between fertility drugs use and malignant melanoma incidence

T2 - the state of the art

AU - Tomao, Federica

AU - Papa, Anselmo

AU - Lo Russo, Giuseppe

AU - Zuber, Sara

AU - Spinelli, Gian Paolo

AU - Rossi, Luigi

AU - Caruso, Davide

AU - Prinzi, Natalie

AU - Stati, Valeria

AU - Benedetti Panici, Pierluigi

AU - Tomao, Silverio

PY - 2014/10/9

Y1 - 2014/10/9

N2 - The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma.

AB - The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma.

KW - Fertility drugs

KW - In vitro fertilization

KW - Infertility

KW - Invasive melanoma

KW - Ovarian stimulation

UR - http://www.scopus.com/inward/record.url?scp=84919863003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919863003&partnerID=8YFLogxK

U2 - 10.1007/s13277-014-2230-4

DO - 10.1007/s13277-014-2230-4

M3 - Article

C2 - 24969557

AN - SCOPUS:84919863003

VL - 35

SP - 8415

EP - 8424

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 9

ER -